Trends of drug-resistant tuberculosis in Kaunas region

A. Naudziunas, A. Andriuskeviciene, T. Furmonavicius (Kaunas, Lithuania)

Source: Annual Congress 2004 - Problems of resistances in tuberculosis
Session: Problems of resistances in tuberculosis
Session type: Thematic Poster Session
Number: 3977
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Naudziunas, A. Andriuskeviciene, T. Furmonavicius (Kaunas, Lithuania). Trends of drug-resistant tuberculosis in Kaunas region. Eur Respir J 2004; 24: Suppl. 48, 3977

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Drug-resistant tuberculosis in Lithuania (Kaunas region)
Source: Eur Respir J 2001; 18: Suppl. 33, 513s
Year: 2001

Trends of multidrug-resistant tuberculosis clustering in Portugal
Source: ERJ Open Res, 5 (1) 00151-2018; 10.1183/23120541.00151-2018
Year: 2019



Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
Source: Eur Respir J 2012; 39: 1425-1431
Year: 2012



Our experience with multiple drug-resistant tuberculosis in Plovdiv Region, Bulgaria – 1999–2004
Source: Eur Respir J 2006; 28: Suppl. 50, 379s
Year: 2006

Multiple drug-resistant tuberculosis in Plovdiv region (Bulgaria)-1989-2001
Source: Eur Respir J 2002; 20: Suppl. 38, 612s
Year: 2002

Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus
Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview
Year: 2012


Epidemiology of TB
Source: Eur Respir Mon 2012; 58: 14-25
Year: 2012


Trends of tuberculosis in a pneumology service in Bucharest
Source: Eur Respir J 2005; 26: Suppl. 49, 194s
Year: 2005

Tuberculosis in Estonia: a major impact of Russian MDR Mycobacterium tuberculosis Beijing B0/W148-cluster
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


The Beijing genotype dominates the multidrug-resistant Mycobacterium tuberculosis population in North-West Russia
Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection
Year: 2021


Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Mutations in the genes of drug-resistant mycobacterium tuberculosis in Uzbekistan
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Tendencies in the tuberculosis incidence evolution in Bucharest, Romania
Source: Eur Respir J 2004; 24: Suppl. 48, 192s
Year: 2004

Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Risk factors for multidrug-resistant and extensively drug-resistant tuberculosis in Estonia
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008

Prevalence of the epidemic variants of the Mycobacterium tuberculosis Beijing genotype across Russian regions
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021


Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city
Source: Eur Respir J 2013; 41: 901-908
Year: 2013



The global risk of dying from multidrug-resistant tuberculosis (MDR-TB)
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014

Study of isoniazid-resistant tuberculosis including outcomes in a high prevalence area in London
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012